QuidelOrtho Corporation Common Stock
Here’s whether QuidelOrtho Corporation Common Stock (QDEL) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: 50-day MA is rising (+0.71% over 10 days); RSI 38 — healthy momentum range; 3-month momentum positive (+24.3%). Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); weak 1-year return of -42.6%; rising volume on a downtrend (distribution, 1.16x avg). Currently 58.6% off its 52-week high. Score: -1/7.
QDEL is trading below its 200-day MA ($19.85) — a key warning sign the longer-term trend is under pressure. An RSI of 37.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -42.6% compares to +20.5% for SPY (trailed the market by 63.0%). The current 58.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.